Inspire Medical Systems, Inc. to Report Third Quarter 2021 Financial Results on November 2, 2021

October 5, 2021 8:00 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

MINNEAPOLIS, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the third quarter 2021 after the close of trading on Tuesday, November 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

  
Tuesday, November 2nd @ 5:00 p.m. Eastern Time:
Domestic:800-344-0786 
International:209-905-5969 
Conference ID:8449129 
Webcast:https://edge.media-server.com/mmc/p/utdpmguo 

About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:Bob YedidLifeSci Advisorsinspire@lifesciadvisors.com646-597-6989

Primary Logo

Source: Inspire Medical Systems, Inc.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Globe Newswire, Press Releases

Related Entities

Earnings, FDA